Reply to Ward and Colleagues’ Comment on “Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”

Rebecca N. Jerome (), Jill M. Pulley, Dan M. Roden, Jana K. Shirey-Rice, Lisa A. Bastarache, Gordon Bernard, Leeland Ekstrom, William J. Lancaster and Joshua C. Denny
Additional contact information
Rebecca N. Jerome: Vanderbilt University Medical Center
Jill M. Pulley: Vanderbilt University Medical Center
Dan M. Roden: Vanderbilt University Medical Center
Jana K. Shirey-Rice: Vanderbilt University Medical Center
Lisa A. Bastarache: Vanderbilt University School of Medicine
Gordon Bernard: Vanderbilt University Medical Center
Leeland Ekstrom: Vanderbilt University Medical Center
William J. Lancaster: Vanderbilt University School of Medicine
Joshua C. Denny: Vanderbilt University School of Medicine

Drug Safety, 2018, vol. 41, issue 11, No 11, 1101 pages

Date: 2018
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-018-0701-z Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0701-z

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-018-0701-z

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().